UBS Group AG

Position in RGNX — REGENXBIO Inc.

CIK 1610520 ZURICH, V8

Back to RGNX Full portfolio

Position in RGNX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$2,157,539

-$818,782 QoQ

Shares Held

257,463

+24.6% QoQ

Ownership

0.498%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 92.97646652140308.ToString("F0")% Shared 0.ToString("F0")% None 7.023533478596924.ToString("F0")%

Common Shares in RGNX Over Time

Shares Held

Position Value (USD)

Derivatives in RGNX

reported options exposure · as of Dec 31, 2023

CallValue

$96,930

CallShares

5,400

PutValue

$884,935

PutShares

49,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. RGNX ranks #204 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

All Filings in RGNX

Export CSV

33 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,157,539	257,463	+24.6%	Shares	Defined	2026-05-05
2025-12-31	$2,976,321	206,689	-21.2%	Shares	Defined	2026-01-29
2025-09-30	$2,532,352	262,420	-14.8%	Shares	Defined	2025-11-13
2025-06-30	$2,527,645	307,874	+54.3%	Shares	Defined	2025-08-14
2025-03-31	$1,426,918	199,569	+3.2%	Shares	Defined	2025-05-13
2024-12-31	$1,494,231	193,303	+73.4%	Shares	Defined	2025-02-14
2024-09-30	$1,169,476	111,485	+8.1%	Shares	Defined	2024-11-14
2024-06-30	$1,206,620	103,130	-27.1%	Shares	Defined	2024-08-14
2024-03-31	$2,979,719	141,420	+2518.9%	Shares	Defined	2024-05-13
2023-12-31	$96,930	5,400	-89.0%	Call	Defined	2024-02-09
2023-12-31	$884,935	49,300	-66.7%	Put	Defined	2024-02-09
2023-12-31	$2,660,710	148,229	+121.2%	Shares	Defined	2024-02-09
2023-09-30	$1,102,786	66,998	+35.9%	Shares	Defined	2023-11-09
2023-09-30	$811,478	49,300	0.0%	Call	Defined	2023-11-09
2023-09-30	$811,478	49,300	-21.0%	Put	Defined	2023-11-09
2023-06-30	$1,247,375	62,400	+26.6%	Shares	Defined	2023-08-11
2023-06-30	$985,507	49,300	0.0%	Put	Defined	2023-08-11
2023-06-30	$985,507	49,300	-29.1%	Call	Defined	2023-08-11
2023-03-31	$1,315,775	69,581	-38.3%	Shares	Defined	2023-05-12
2022-12-31	$2,557,510	112,765	+192.3%	Shares	Defined	2023-02-08
2022-09-30	$1,019,484	38,573	-23.5%	Shares	Defined	2022-11-10
2022-06-30	$1,245,497	50,425	-9.7%	Shares	Defined	2022-08-10
2022-03-31	$1,852,631	55,819	-88.1%	Shares	Defined	2022-05-16
2021-12-31	$15,352,354	469,491	-12.9%	Shares	Defined	2022-02-14
2021-09-30	$22,595,759	539,021	+5290.2%	Shares	Defined	2021-11-15
2021-09-30	$419,200	10,000	-75.8%	Call	Defined	2021-11-15
2021-09-30	$1,732,888	41,338	-92.1%	Put	Defined	2021-11-15
2021-06-30	$20,379,505	524,569	+8.4%	Shares	Defined	2021-08-13
2021-03-31	$16,509,376	484,004	+9.0%	Shares	Defined	2021-05-12
2020-12-31	$20,132,445	443,837	-33.0%	Shares	Defined	2021-02-11
2020-09-30	$18,229,578	662,412	+120.8%	Shares	Defined	2020-11-12
2020-06-30	$11,050,399	300,038	-52.0%	Shares	Defined	2020-07-31
2020-03-31	$20,257,736	625,625	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.